JPMorgan Chase & Co’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1
Closed 6419
2023
Q1
$0 Hold
1
﹤0.01% 6280
2022
Q4
$0 Buy
+1
New ﹤0.01% 6140
2019
Q4
Sell
-27,216
Closed -$286K 4930
2019
Q3
$286K Sell
27,216
-310,899
-92% -$3.27M ﹤0.01% 3588
2019
Q2
$6.73M Sell
338,115
-80,887
-19% -$1.61M ﹤0.01% 1965
2019
Q1
$14.1M Buy
419,002
+19,423
+5% +$655K ﹤0.01% 1530
2018
Q4
$11.7M Buy
399,579
+12,139
+3% +$354K ﹤0.01% 1576
2018
Q3
$23.9M Buy
387,440
+30,082
+8% +$1.85M ﹤0.01% 1327
2018
Q2
$26.4M Buy
357,358
+71,054
+25% +$5.24M 0.01% 1225
2018
Q1
$18.8M Buy
286,304
+52,397
+22% +$3.44M ﹤0.01% 1395
2017
Q4
$19.7M Buy
233,907
+7,596
+3% +$639K ﹤0.01% 1390
2017
Q3
$26.2M Sell
226,311
-20,364
-8% -$2.36M 0.01% 1181
2017
Q2
$28.8M Buy
246,675
+22,767
+10% +$2.66M 0.01% 1105
2017
Q1
$27.6M Buy
223,908
+11,448
+5% +$1.41M 0.01% 1130
2016
Q4
$28.9M Sell
212,460
-10,946
-5% -$1.49M 0.01% 1088
2016
Q3
$44.5M Sell
223,406
-12,133
-5% -$2.41M 0.01% 811
2016
Q2
$30.5M Sell
235,539
-8,278
-3% -$1.07M 0.01% 994
2016
Q1
$22.8M Buy
243,817
+61,688
+34% +$5.77M 0.01% 1134
2015
Q4
$36.9M Buy
182,129
+62,962
+53% +$12.8M 0.01% 868
2015
Q3
$17.3M Buy
119,167
+26,731
+29% +$3.88M ﹤0.01% 1238
2015
Q2
$19.7M Buy
92,436
+5,966
+7% +$1.27M ﹤0.01% 1274
2015
Q1
$20M Buy
86,470
+36,713
+74% +$8.51M ﹤0.01% 1313
2014
Q4
$11.5M Buy
+49,757
New +$11.5M ﹤0.01% 1613